Literature DB >> 23541921

Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal.

Yue Wang1, Zhenyu Xu, Junfeng Jiang, Chen Xu, Jiuhong Kang, Lei Xiao, Minjuan Wu, Jun Xiong, Xiaocan Guo, Houqi Liu.   

Abstract

The embryonic stem cell (ESC) transcriptional and epigenetic networks are controlled by a multilayer regulatory circuitry, including core transcription factors (TFs), posttranscriptional modifier microRNAs (miRNAs), and some other regulators. However, the role of large intergenic noncoding RNAs (lincRNAs) in this regulatory circuitry and their underlying mechanism remains undefined. Here, we demonstrate that a lincRNA, linc-RoR, may function as a key competing endogenous RNA to link the network of miRNAs and core TFs, e.g., Oct4, Sox2, and Nanog. We show that linc-RoR shares miRNA-response elements with these core TFs and that linc-RoR prevents these core TFs from miRNA-mediated suppression in self-renewing human ESC. We suggest that linc-RoR forms a feedback loop with core TFs and miRNAs to regulate ESC maintenance and differentiation. These results may provide insights into the functional interactions of the components of genetic networks during development and may lead to new therapies for many diseases.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23541921     DOI: 10.1016/j.devcel.2013.03.002

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  362 in total

Review 1.  LncRNAs: emerging players in gene regulation and disease pathogenesis.

Authors:  Mina Kazemzadeh; Reza Safaralizadeh; Ayla Valinezhad Orang
Journal:  J Genet       Date:  2015-12       Impact factor: 1.166

2.  Competing endogenous RNA: A novel posttranscriptional regulatory dimension associated with the progression of cancer.

Authors:  Qingsong Dai; Jixia Li; Keyuan Zhou; Tong Liang
Journal:  Oncol Lett       Date:  2015-09-14       Impact factor: 2.967

Review 3.  Endometrial stem cells: clinical application and pathological roles.

Authors:  Yanping Xu; Huiting Zhu; Dongni Zhao; Jichun Tan
Journal:  Int J Clin Exp Med       Date:  2015-12-15

4.  Altered expression of LINC-ROR in cancer cell lines and tissues.

Authors:  Majdaddin Rezaei; Modjtaba Emadi-Baygi; Michèle J Hoffmann; Wolfgang A Schulz; Parvaneh Nikpour
Journal:  Tumour Biol       Date:  2015-08-28

Review 5.  Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis.

Authors:  Binod Aryal; Yajaira Suárez
Journal:  Vascul Pharmacol       Date:  2018-03-15       Impact factor: 5.773

6.  Changes in cellular mRNA stability, splicing, and polyadenylation through HuR protein sequestration by a cytoplasmic RNA virus.

Authors:  Michael D Barnhart; Stephanie L Moon; Alexander W Emch; Carol J Wilusz; Jeffrey Wilusz
Journal:  Cell Rep       Date:  2013-11-07       Impact factor: 9.423

7.  Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells.

Authors:  Yu Lu; Yuin-Han Loh; Hu Li; Marcella Cesana; Scott B Ficarro; Jignesh R Parikh; Nathan Salomonis; Cheng-Xu Delon Toh; Stelios T Andreadis; C John Luckey; James J Collins; George Q Daley; Jarrod A Marto
Journal:  Cell Stem Cell       Date:  2014-05-08       Impact factor: 24.633

8.  Non-Coding RNA Pvt1 Promotes Cancer Stem Cell-Like Traits in Nasopharyngeal Cancer via Inhibiting miR-1207.

Authors:  Meng Cui; Yu Chang; Qi-Gen Fang; Wei Du; Jun-Fu Wu; Ji-Heng Wang; Shan-Ting Liu; Su-Xia Luo
Journal:  Pathol Oncol Res       Date:  2018-08-23       Impact factor: 3.201

Review 9.  AUF1 regulation of coding and noncoding RNA.

Authors:  Elizabeth J F White; Aerielle E Matsangos; Gerald M Wilson
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-09-13       Impact factor: 9.957

10.  Modulation of hypoxia-signaling pathways by extracellular linc-RoR.

Authors:  Kenji Takahashi; Irene K Yan; Hiroaki Haga; Tushar Patel
Journal:  J Cell Sci       Date:  2014-01-24       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.